Clinical Trial Update: Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015% [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of large-scale field-directed topical ingenol mebutate 0.015% for actinic keratosis of the chest has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• ingenol mebutate 0.015% (ingenol mebutate)

Snippet

Sponsor: Goldman, Butterwick, Fitzpatrick and Groff | Conditions: Actinic Keratosis | Phase 4 | Status: COMPLETED | Results posted: 2019-09-06